The diseases treated with cord blood today fall into a narrower and more specific group than most search results suggest. Cord blood stem cells are used in transplant procedures for certain blood cancers, inherited and acquired blood disorders, severe immune deficiencies, and a small set of inherited metabolic conditions. That list is real, it is decades old, and it is backed by peer-reviewed evidence — but it is not the sweeping "cord blood cures almost anything" promise that fills a lot of the internet.
We think you deserve the accurate version. Below is a clear breakdown of what cord blood stem cells are actually used for, what is still being researched, and how transplant with cord blood works in practice — so you can decide what banking is worth to your family with real information in hand.
What Can Cord Blood Stem Cells Actually Treat?
Cord blood stem cells are used in hematopoietic stem cell transplants to rebuild a patient's blood and immune system. In the United States, FDA-licensed cord blood products carry a single, deliberately broad indication: use in unrelated donor hematopoietic progenitor cell transplantation, alongside an appropriate preparative regimen, "for hematopoietic and immunologic reconstitution in patients with disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment."
In plainer terms: cord blood is approved as a source of blood-forming stem cells for transplant. The condition being treated has to be one where a stem cell transplant is the accepted therapy.
One language note that matters, because it shapes everything else on this page. Many people search for what cord blood cures. "Used in transplants for" is the accurate phrasing. A transplant can put a disease into long-term remission and, in some inherited conditions, correct the underlying defect — but the treatment is the transplant, not the cord blood on its own, and outcomes depend on the patient, the disease stage, the conditioning regimen and the match quality.
Blood Cancers and Disorders Treated With Cord Blood
This is the largest and best-established category, and it is where the great majority of cord blood transplants happen.
- Leukemia — acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia and related myeloid malignancies. Leukemia is the single most-searched condition in this category, and for good reason: it is the most common reason a cord blood unit gets used.
- Lymphoma — including Hodgkin and non-Hodgkin lymphoma, where transplant is indicated after relapse or in high-risk disease.
- Myelodysplastic syndromes (MDS) and other bone marrow failure syndromes.
- Sickle cell disease — where allogeneic transplant is the only established curative-intent therapy outside of newer gene therapies.
- Thalassemia — particularly transfusion-dependent beta thalassemia major.
- Aplastic anemia — severe acquired aplastic anemia, where the marrow stops producing blood cells.
- Fanconi anemia and other inherited bone marrow failure disorders.
The evidence base here is substantial. A 2021 trial published in Blood (BMT CTN 1101) compared double unrelated umbilical cord blood transplantation against HLA-haploidentical bone marrow transplantation in adults with high-risk leukemia and lymphoma, and a 2017 collaborative analysis in Leukemia pooling CIBMTR, Eurocord and EBMT registry data found cord blood transplant outcomes comparable to other graft sources in FLT3-mutated AML. For sickle cell disease specifically, a 2022 review in Transfusion and Apheresis Science examined umbilical cord blood as a stem cell source in pediatric patients, including both the promise and the real challenges around cell dose and engraftment.
Worth being straight about: in most of these cases the transplant uses cells from a donor — a sibling, or an unrelated unit from a public registry. A baby's own banked cord blood cannot be used to treat that same child's genetic disorder, because the cells carry the same genetic change. Where a family's own banked unit becomes most valuable is as a matched source for a sibling, which is one of the practical reasons families bank privately. We cover that trade-off honestly in our guide to public versus private cord blood banking.
Immune System Disorders Treated With Cord Blood
Severe inherited immune deficiencies were among the earliest successful uses of cord blood transplant, and remain a core indication.
- Severe combined immunodeficiency (SCID) — the "bubble baby" disorders, where a transplant early in life is the standard of care and timing strongly affects survival.
- Wiskott-Aldrich syndrome
- Chronic granulomatous disease (CGD)
- Hemophagocytic lymphohistiocytosis (HLH)
- Other combined immunodeficiencies where hematopoietic cell transplant is the accepted treatment
A 2021 retrospective study in the Journal of Clinical Immunology reviewed hematopoietic cell transplantation outcomes for SCID patients across a national Japanese cohort, with cord blood among the graft sources used. For these conditions, speed matters enormously — and this is one of cord blood's genuine clinical advantages, because banked units are already collected, typed and frozen, so they can be released in days rather than the weeks an adult donor workup can take.
Metabolic Disorders Treated With Cord Blood
This category is real but narrow, and the evidence is more specialized. Transplant is used in a small number of inherited metabolic disorders where donor stem cells can supply a missing enzyme and slow or halt neurological damage.
- Krabbe disease (globoid cell leukodystrophy)
- Hurler syndrome (MPS I)
- Metachromatic leukodystrophy
- Adrenoleukodystrophy (ALD)
- Sanfilippo syndrome (MPS III) in selected cases
The landmark work here is a 2005 study in the New England Journal of Medicine on transplantation of umbilical cord blood in babies with infantile Krabbe's disease, which found that newborns transplanted before symptoms appeared had substantially better neurodevelopmental outcomes than those transplanted after symptom onset. That finding is the reason newborn screening for these conditions matters so much — the treatment window can close within weeks of birth.
Conditions Being Researched for Future Cord Blood Treatment
These are not currently approved treatments. Everything in this section is investigational — studied in clinical trials, not available as standard therapy, and not something any bank can promise you.
- Cerebral palsy — a 2017 randomized, placebo-controlled trial in Stem Cells Translational Medicine tested autologous cord blood infusion on motor function and brain connectivity in young children with cerebral palsy.
- Autism spectrum disorder — a 2020 phase II randomized clinical trial in The Journal of Pediatrics evaluated intravenous umbilical cord blood infusion in children with ASD.
- Type 1 diabetes
- Hypoxic-ischemic encephalopathy in newborns
- Acquired hearing loss
- Certain autoimmune conditions
How Cord Blood Stem Cells Are Used in Treatment
Understanding the mechanics helps explain why the approved list looks the way it does.
1. Conditioning. The patient receives chemotherapy, sometimes with radiation, to clear out the diseased or malfunctioning bone marrow and suppress the immune system enough to accept new cells.
2. Infusion. The thawed cord blood unit is delivered intravenously, much like a blood transfusion. There is no surgery involved.
3. Engraftment. The infused hematopoietic stem cells travel to the bone marrow and begin producing healthy red cells, white cells and platelets. Engraftment with cord blood is typically slower than with bone marrow or peripheral blood — usually two to four weeks — which is one of its known trade-offs.
4. Recovery. Immune reconstitution continues over months, with monitoring for infection and graft-versus-host disease (GvHD).
Cord blood earns its place as a graft source for three specific reasons.
- Its immune cells are immunologically naive, so it tolerates a less-than-perfect HLA match than an adult donor would — which materially widens access for patients from mixed or underrepresented ethnic backgrounds who struggle to find matches on adult registries.
- It carries a lower risk of chronic GvHD at equivalent match levels.
- And it is available immediately, already tested and frozen.
The main constraint is volume: a single cord blood unit contains a fixed number of cells, and cell dose relative to patient weight is one of the strongest predictors of engraftment. This is exactly why collection quality and storage method matter. AlphaCord's 3-in-1 kit is temperature-protected and electronically tracked from collection to cryostorage, and units are stored in a 5-chamber bag — meaning a single collection can be released in separate portions for up to five treatments rather than being spent all at once.
Whether banking makes sense for your family is a separate question from what cord blood can treat, and it comes down to family medical history, sibling considerations and budget. Our complete guide to cord blood banking walks through the decision, and what cord blood banking costs breaks down the real numbers with no padding.
Frequently Asked Questions
What diseases can cord blood treat?
Cord blood stem cells are used in transplants for blood cancers (leukemia, lymphoma, myelodysplastic syndromes), inherited and acquired blood disorders (sickle cell disease, thalassemia, aplastic anemia, Fanconi anemia), severe immune deficiencies (including SCID, Wiskott-Aldrich syndrome and chronic granulomatous disease), and a small group of inherited metabolic disorders such as Krabbe disease, Hurler syndrome and adrenoleukodystrophy. In every case, the treatment is a hematopoietic stem cell transplant for which cord blood serves as the cell source.
Can cord blood cure leukemia?
This is the most common way people phrase the question, and it deserves a direct answer rather than a dodge. Cord blood is not a cure on its own. It is used as the stem cell source in an allogeneic transplant, which is a potentially curative treatment for leukemia — patients can and do achieve long-term, disease-free survival after cord blood transplant. But the curative effect comes from the whole protocol: conditioning chemotherapy that destroys the leukemic cells, followed by transplanted donor stem cells that rebuild a healthy blood and immune system, plus a donor immune effect against any remaining cancer cells. Outcomes depend on disease type, remission status at transplant, patient age and match quality.
Is cord blood used for autism or cerebral palsy?
Only in clinical trials. Neither use is an approved treatment. Researchers at several centers have run randomized trials infusing cord blood in children with cerebral palsy and autism spectrum disorder, and results so far are mixed — some encouraging signals, some trials that did not meet their primary endpoints.
How many diseases can cord blood currently treat?
You will see the figure "80+ diseases" across the industry, including in our own materials, and it is worth understanding exactly what it means. It reflects the range of individual diagnoses for which hematopoietic stem cell transplant — with cord blood as one accepted cell source — has been used in clinical practice, counted disease by disease.
Understand the Full Picture Before You Decide
Now that you know what cord blood stem cells are actually used for, the next question is a practical one: does banking make sense for your family, and what does it really cost?
We were founded in 2002 by parents who thought cord blood banking was priced out of reach for ordinary American families, and that has not changed how we operate. AABB accredited, AATB accredited, FDA registered, with an engraftment guarantee of up to $85,000 if stored cells fail to engraft — and pricing that starts at $81 a month.
→ Learn How Cord Blood Banking Works
No obligation, no pressure. When you are ready:
